Non-Epithelial Fibroblasts represent a diverse group of cells found in various tissues, distinct from the epithelial cell lineage. These cells, commonly known as stromal fibroblasts, play crucial roles in tissue homeostasis, repair, and the maintenance of structural integrity. Unlike epithelial cells that form the lining of organs and surfaces, non-epithelial fibroblasts are embedded within the extracellular matrix, contributing to the structural framework of tissues. In the context of wound healing and tissue repair, non-epithelial fibroblasts are key players in the formation of granulation tissue. They actively synthesize and deposit extracellular matrix components, including collagen, fibronectin, and proteoglycans, creating a supportive environment for tissue regeneration. Fibroblasts also produce growth factors and cytokines that modulate immune responses and coordinate cellular activities during the healing process. These cells are highly dynamic, responding to environmental cues and signals from neighboring cells. Fibroblasts can differentiate into myofibroblasts, which possess contractile properties and play a crucial role in tissue contraction during wound healing. Additionally, non-epithelial fibroblasts contribute to the regulation of inflammation, angiogenesis, and tissue remodeling through their interactions with immune cells and endothelial cells. While traditionally studied in the context of connective tissues, recent research has expanded the understanding of non-epithelial fibroblasts in various organs, including the heart, liver, and lungs. Their involvement in fibrotic diseases, cancer progression, and organ-specific functions underscores the significance of investigating these cells in diverse physiological and pathological contexts. In summary, non-epithelial fibroblasts represent a versatile and essential cell population, contributing to tissue structure, repair, and modulation of biological processes. Unraveling the complexities of their functions in different tissues holds promise for advancing therapeutic strategies in wound healing, tissue regeneration, and the treatment of diseases associated with fibrosis and dysregulated tissue remodeling.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy